Delivery Order SPE2DR25D6029-SPE2DR26FXT1K

<p>The Defense Logistics Agency issued a $1,274.90 delivery order to Amerisourcebergen Drug Corp on March 30, 2026, for Aranesp 60 mcg/0.3 mL syringes under a firm fixed-price arrangement with an ultimate completion date of March 31, 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries no set-aside designation and was competitively awarded.</p>

<p>The Defense Logistics Agency issued a $6,260.82 delivery order to AmerisourceBergen Drug Corp on March 24, 2026, for Aranesp 100 mcg/0.5 ml syringes under a firm fixed-price arrangement. Ultimate completion date is March 25, 2026. Place of performance is Conshohocken, PA. The order was not set-aside and carries no socioeconomic restrictions.</p>

<p>The Defense Logistics Agency issued a $1,912.35 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Aranesp 60 mcg/0.3 ml syringes with an ultimate completion date of February 6, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is issued under firm fixed pricing with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a $1,638.81 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for Aranesp 150 mcg/0.3 mL syringes under firm fixed-price terms. Ultimate completion is March 11, 2026.</p> <p>Place of performance is Conshohocken, Pennsylvania. The order carries no set-aside designation and was competitively awarded. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs.</p>

The Defense Logistics Agency issued a $2,203.10 delivery order to Amerisourcebergen Drug Corp on April 3, 2026, for Aranesp 25 mcg/0.42 mL syringes. The order is issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which provides pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries a firm...

<p>The Defense Logistics Agency issued a $2,086.94 delivery order to Amerisourcebergen Drug Corp on February 18, 2026, for Aranesp 100 mcg/0.5 mL syringes.</p> <p>Place of performance is Conshohocken, PA. The order carries a ceiling value of $2,086.94 with an ultimate completion date of February 19, 2026, and is priced on a firm fixed-price basis. No set-aside was used for this order.</p>

The Defense Logistics Agency issued a $1,011.74 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Aranesp 200 mcg/0.4 mL syringes under a firm fixed-price arrangement. The order was placed against the company's Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 vehicle running through December 2026 that supplies pharmaceutical products and medical commodities globally to military healthcare programs. Place of performance is Conshohocken, PA. The...

The Defense Logistics Agency issued a $3,877.20 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for Aranesp 40 mcg/0.4 mL syringes under a firm fixed-price award with an ultimate completion date of March 6, 2026. Place of performance is Conshohocken, PA. The order carries no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through the Defense Logistics Agency's Medical...

<p>The Defense Logistics Agency issued a $17,225.24 delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for ARANESP 500 MCG/1 ML syringes.</p> <p>Place of performance is Conshohocken, PA. The order has a ceiling value of $17,225.24 and an ultimate completion date of February 26, 2026. Pricing is firm fixed price. The order was not set aside.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, with a ceiling value of $11,411.76 for Aranesp(epoetin alfa) 500 mcg/1 mL syringes.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 9, 2026 and is priced on a firm fixed-price basis. No set-aside was used.</p>